Rating History for GW Pharma (GWPH) by Morgan Stanley
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/4/2021 | David Lebowitz | Downgrade | Equalweight (Overweight) |
220.00 (193.00) |
146.25 (218.96) |
49.72% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
